Active substances
Oxycodone + Paracetamol
- US FDA 65
- Health Canada 3
- US price lines 9
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| OXYCET | 325MG;5MG | tablet · oral | SPECGX LLC | Prescription | 7 Dec 1983 |
| PERCOCET | 325MG;2.5MG; 325MG;5MG; 325MG;7.5MG; 325MG;10MG | tablet · oral | OZANTRI | Prescription | 25 Jun 1999 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG; 325MG;10MG | tablet · oral | SPECGX LLC | Prescription | 30 Jun 2004 |
| OXYCODONE AND ACETAMINOPHEN | 300MG;2.5MG; 300MG;5MG; 300MG;7.5MG; 300MG;10MG | tablet · oral | PHARMOBEDIENT | Prescription | 30 Dec 2005 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | tablet · oral | AMNEAL PHARMS | Prescription | 27 Nov 2007 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;10MG; 325MG;7.5MG | tablet · oral | AMNEAL PHARMS NY | Prescription | 27 Nov 2007 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;7.5MG; 325MG;10MG; 325MG;5MG | tablet · oral | ALVOGEN | Prescription | 26 Jul 2012 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;2.5MG; 325MG;5MG; 325MG;7.5MG; 325MG;10MG | tablet · oral | ACTAVIS ELIZABETH | Prescription | 12 Apr 2013 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;2.5MG; 325MG;5MG; 325MG;7.5MG; 325MG;10MG | tablet · oral | AUROLIFE PHARMA LLC | Prescription | 15 Jul 2013 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;5MG; 325MG;7.5MG; 325MG;10MG | tablet · oral | RHODES PHARMS | Prescription | 28 Aug 2014 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;2.5MG; 325MG;5MG; 325MG;7.5MG; 325MG;10MG | tablet · oral | NOVEL LABS INC | Prescription | 24 Feb 2017 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;2.5MG; 325MG;5MG; 325MG;7.5MG; 325MG;10MG | tablet · oral | ASCENT PHARMS INC | Prescription | 22 Mar 2017 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;5MG; 325MG;10MG | tablet · oral | LANNETT CO INC | Prescription | 25 Sep 2017 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;2.5MG; 325MG;5MG; 325MG;7.5MG; 325MG;10MG | tablet · oral | ABHAI LLC | Prescription | 9 Feb 2018 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;5MG; 325MG;7.5MG; 325MG;10MG | tablet · oral | WES PHARMA INC | Prescription | 21 Mar 2018 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;5MG; 325MG;7.5MG; 325MG;10MG | tablet · oral | EPIC PHARMA LLC | Prescription | 2 Jul 2018 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;5MG; 325MG;7.5MG; 325MG;10MG | tablet · oral | ELITE LABS INC | Prescription | 2 Jul 2018 |
| OXYCODONE AND ACETAMINOPHEN | 300MG/5ML;10MG/5ML | solution · oral | PHARMOBEDIENT | Prescription | 27 Nov 2018 |
| OXYCODONE AND ACETAMINOPHEN | 325MG/5ML;5MG/5ML | solution · oral | ABHAI LLC | Prescription | 31 Dec 2018 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;2.5MG; 325MG;5MG; 325MG;7.5MG; 325MG;10MG | tablet · oral | GRANULES | Prescription | 31 Oct 2019 |
| PERCOCET | 325MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | OZANTRI | Discontinued | 31 Aug 1976 |
| OXYCODONE 2.5/APAP 500 | 500MG;2.5MG | tablet · oral | BRISTOL MYERS SQUIBB | Discontinued | 25 Oct 1977 |
| OXYCODONE 5/APAP 500 | 500MG;5MG | tablet · oral | BRISTOL MYERS SQUIBB | Discontinued | 25 Oct 1977 |
| ROXICET | 325MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | HIKMA PHARMS | Discontinued | 25 Feb 1980 |
| OXYCODONE AND ACETAMINOPHEN | 325MG;5MG | tablet · oral | BARR | Discontinued | 2 Nov 1981 |
40 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO-OXYCODONE/ACET | 02324628 | 5 MG; 325 MG | TABLET · ORAL | APOTEX INC |
| RIVACOCET | 02242468 | 5 MG; 325 MG | TABLET · ORAL | LABORATOIRE RIVA INC. |
| TEVA-OXYCOCET | 00608165 | 5 MG; 325 MG | TABLET · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | OXYCODONE-ACETAMINOPHEN 10-325 MG TAB | $0.23081 | per EA | 23 Sep 2026 |
| US NADAC | OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET | $0.23081 | per EA | 23 Sep 2026 |
| US NADAC | OXYCODONE-ACETAMINOPHEN 2.5-325 MG TABLET | $0.76157 | per EA | 23 Sep 2026 |
| US NADAC | OXYCODONE-ACETAMINOPHEN 5-325 MG TAB | $0.11705 | per EA | 23 Sep 2026 |
| US NADAC | OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET | $0.11705 | per EA | 23 Sep 2026 |
| US NADAC | OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET | $0.18251 | per EA | 23 Sep 2026 |
| US NADAC | PERCOCET 10-325 MG TABLET | $41.39519 | per EA | 23 Sep 2026 |
| US NADAC | PERCOCET 5-325 MG TABLET | $29.31652 | per EA | 23 Sep 2026 |
| US NADAC | PERCOCET 7.5-325 MG TABLET | $31.60483 | per EA | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.